← Back to Semax

VS Peps · Certificate № JN-260505-1218

Certificate of Analysis

Compound identity

SMX

Semax

ACTH(4–10) analog · 30mg lyophilized

Batch identifiers

Batch IDJN-260505-1218
Lab referenceLR-90706
Test date2026-05-05
Format30mg · lyophilized

HPLC Analysis

High-Performance Liquid Chromatography

Reported purity

99.3%

Area under the target peak as a percentage of total area.

Batch · 2026-05-05Janoshik Analytical · HPLC
99.3%SMX2 MIN5 MIN8 MIN12 MIN

Identity verification

Compound nameSemax
Editorial codeSMX
Molecular formConfirmed by MS
Test methodRP-HPLC / UV-Vis
Reference standardIn-house standard, characterized
Storage at testLyophilized, sealed vial, RT

Structure

7residues
3-letter notation
1Met2Glu3His4Phe5Pro6Gly7Pro

Modifications

  • 01ACTH(4–10) analog with Pro-Gly-Pro extension

Sourcing & storage

Sourcing chain

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & handling

Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 30 days. Research use only.

Lab analyst signature

Janoshik Analytical

Verified · 2026-05-05

Document control

Certificate № JN-260505-1218Issued 2026-05-05Format RP-HPLC / UVDistribution Per-product page

Research use only. This certificate documents analytical results for the batch identified above. Products are sold strictly for laboratory and research applications and are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. The information herein is provided in good faith based on third-party HPLC analysis but is not a guarantee or warranty. See Research Use Disclaimer for full terms.